© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
May 25, 2022
Data gathered from electronic medical records found that the results in a real-world patient population with atopic dermatitis were consistent with those found in clinical trials.
New survey from American Medical Association identifies the continued burden of prior authorizations on physicians.
May 20, 2022
Rates dipped in the 1990s, but the opioid epidemic and the contaminated needles associated with it have caused an increase in new acute cases.
May 09, 2022
Safe and effective long-term treatment is important for stable disease control in atopic dermatitis.
May 05, 2022
Patients with eosinophilic esophagitis (EoE) are faced with delayed diagnosis, burdens related to symptoms, quality of life and cost, but lack targeted systemic therapies to improve long-term disease control.
March 15, 2022
November 11, 2021
Treating high levels of low-density lipoprotein cholesterol in young people may reduce lifetime exposure and lead to fewer cases of coronary heart disease.
September 16, 2021
States are putting caps on prices, and Semglee, the first interchangeable biosimilar in the United States, may exert some downward pressure.
August 17, 2021
Many people ignored heart disease signs and symptoms during the COVID-19 pandemic — sometimes with grave consequences.
July 21, 2021
After having thrived in a fee-for-service healthcare system, can chronic disease specialists be enticed to switch?